Yes — results are overdue. Primary completion was 2017-09-16; the FDAAA-801 reporting deadline (2018-09-16) passed 2835 days ago and no results are posted on ClinicalTrials.gov.
| NCT ID | NCT03207425 ↗ |
|---|---|
| Sponsor | Enanta Pharmaceuticals, Inc (INDUSTRY) |
| Public issuer | ENANTA PHARMACEUTICALS INC — ENTA (CIK 0001177648) best-effort name match, 95% conf — verify on EDGAR ↗ |
| Phase | PHASE1 |
| Status | COMPLETED |
| Primary completion | 2017-09-16 (ACTUAL) |
| Reporting deadline | 2018-09-16 (completion + 365d) |
| Days overdue | 2835 |
| Results posted | No — check results tab ↗ |
| FDA-regulated | drug: yes, device: no |
| Provenance | Flagged overdue on 2026-06-21 · SHA-256 ff67545f68631ab2… (hash-chained, tamper-evident) |
Source of record: ClinicalTrials.gov NCT03207425. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.